A case report of two systemic lupus erythematosus pregnancies with early placental exposure to belimumab: Case report with review
Author:
Affiliation:
1. Immuno-Rheumatology Center, St. Luke’s International Hospital , Tokyo 104-8560, Japan
2. Center for Clinical Epidemiology, St. Luke’s International University , Tokyo, Japan
3. Department of Rheumatology, Suwa Chuo Hospital , Nagano, Japan
Abstract
Publisher
Oxford University Press (OUP)
Subject
Rheumatology
Link
https://academic.oup.com/mrcr/advance-article-pdf/doi/10.1093/mrcr/rxac069/45801384/rxac069.pdf
Reference20 articles.
1. Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States;Mehta;Ann Intern Med,2019
2. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial;Navarra;Lancet,2011
3. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus;Furie;Arthritis Rheum,2011
4. A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea;Zhang;Ann Rheum Dis,2018
5. Efficacy and safety of subcutaneous belimumab in systemic lupus erythematosus: a fifty-two-week randomized, double-blind, placebo-controlled study;Stohl;Arthritis Rheumatol,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Considering belimumab during pregnancy: A more viable option over time;Lupus;2024-04-09
2. Effect of remission, clinical remission with active serology, and glucocorticoid dosage on the pregnancy outcome of pregnant patients with systemic lupus erythematosus;Arthritis Research & Therapy;2024-03-09
3. A retrospective analysis of the safety of tacrolimus use and its optimal cut-off concentration during pregnancy in women with systemic lupus erythematosus: study from two Japanese tertiary referral centers;Arthritis Research & Therapy;2024-01-04
4. Disease-modifying effect and long-term safety of belimumab in patients with systemic lupus erythematosus: A single-center retrospective study;Lupus;2023-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3